Human paanfluenza virus type 3 (HPIV3) is a major cause of dise In newborns and Infants. It also has a king potential to reinfect individuals throughout their lives, suggesting that HPIV3 does not induce lifelong immunity; however, the operative mechanism for the failure to prevent reinfection is not known. We have as d the potential of the virus to infect nontransformed human Tlymphocytes and have found that T cells are readily infected by the virus. Productive infection requires activation of the T cells and results in a marked inhibition of proliferation. Furthermore, our results indicate that exposure to the virus, even without overt expression of viral proteins as det by imunohistol, profoundly alters the functional capacity of the T cells. The capacity of the virus to regulate T-lymphocyte function may play an important role In the failure of the virus to induce lifelong immunity.
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Human parainfluenza virus type 3 (HPIV3) causes severe respiratory tract infections in infants and children (1) (2) (3) (4) (5) and upper respiratory tract infections in adults (6) (7) (8) . It is efficiently spread from person-to-person (5, 6) ; consequently, all adults possess anti-HPIV3 immunoglobulins (6) .
Persistent infection of the virus has been documented in various clinical situations (8) (9) (10) . Moreover, reinfection after a primary infection with HPIV3 is a common occurrence (1, 6) . In one study the frequency of HPIV3 reinfection was found to be 58% in 1-year-old children and 34% in 2-year-old children (1) . Even in the presence of circulating neutralizing antibodies, adults have been shown to be susceptible to reinfection (6) . This clinical characteristic is distinct from infection with either measles or mumps viruses, which result in lifelong immunity against reinfection. It appears that infection with HPIV3 does not result in the establishment of a state of long-lasting immunity (11) .
The mechanisms for persistent infection or for reinfection with HPIV3 have not been determined; however, it is likely that the equilibrium between the human host and the viral parasite arises as a result ofthe complex interactions between the host's immune system and the virus. One significant aspect of this interaction is infection of T lymphocytes by viruses. Viral infection of T lymphocytes has been demonstrated for many different viruses and has been shown to profoundly alter the immune response (12) (13) (14) (15) . Although T cells have the potential to lyse virally infected cells, help B lymphocytes produce immunoglobulins, and establish longlived memory cells, the possibility that HPIV3-mediated immunoregulation of T lymphocytes plays a role in either persistence or reinfection has not been considered.
In this report we demonstrate that HPIV3 has a marked immunoregulatory effect on human T lymphocytes even in the absence of productive infection as detected by immunohistology. Experiments were also performed by infecting the PBMC with HPIV3 without washing out the virus. The results from these experiments were similar to the results from experiments that were performed with the washing step included (data not shown).
MATERIALS AND METHODS
T cells from the PBMC were activated by adding anti-CD3 (OKT3; Ortho Diagnostics) at a concentration of 2 ng/ml. Activation was inhibited by adding cyclosporin A at a concentration of 500 ng/ml. In some cultures, recombinant interleukin 2 (IL-2) was added at a concentration of 10 units/ml. Restimulation of T cells was accomplished by adding anti-CD3 every 7 days, irradiated (5000 rads; 1 rad = 0.01 Gy) allogeneic PBMC at a density of 106 per ml and IL-2 at a concentration of 10 T-Cell Clones. T-cell clones from three individuals were established and maintained as described (16, 17 (Fig. 1) the cell surface of infected PBMC and a T-cell clone with an antiserum specific for HPIV3 surface glycoproteins showed an apparently single predominant population of infected cells (Fig. 2) . Infection did not appear to clonally discriminate among T cells.
Proiferaton of HPIV3-Infected T Lympbocytes. Although only 30-40% of PBMC or cloned cells were infected, we noted that the viability of the cells in infected cultures gradually diminished over 3 weeks until the cultures no longer contained any viable cells. To more clearly assess the capacity of infected T cells to proliferate, we performed daily cell counts on the cultures shown in Fig. 1 (Fig. 3) . These data show that HPIV3 infection markedly decreased the proliferation of T lymphocytes stimulated with anti-CD3.
Furthermore, although IL-2 reversed the growth inhibition mediated by cyclosporin A of anti-CD3-stimulated T cells in uninfected cultures, the addition of IL-2 along with cyclosporin A to anti-CD3-stimulated cultures infected with HPIV3 did not reverse the inhibition of cellular proliferation (Fig. 3) . This inability to respond to IL-2 could not be explained by a failure in expression ofthe IL-2 receptor. Cells from infected and uninfected cultures expressed equivalent levels of the inducible chain of the IL-2 receptor complex (data not shown). Thus, HPIV3 infection alters the proliferative capacity of T lymphocytes and prevents IL-2 from inducing growth in receptor-positive cells.
A further indication of the virus' effect on T-cell proliferation was demonstrated with another experimental protocol. PBMC were infected with HPIV3 (1 pfu per cell), but activation with anti-CD3 was delayed for 4 days. In uninfected cultures, total cell numbers increased from 2.5 x 106 to 16 x 106 between 3 and 5 days after anti-CD3 activation; however, in the cultures infected with HPIV3, there was no increase in the cell number. The cells stimulated with anti-CD3 4 days after infection did not present any sign of infection, as indicated by immunohistology. Again the functional effect ofthe virus was not dependent on overt infection of the cells.
A functional alteration in the T cells infected with HPIV3 was also indicated by assessing the incorporation of tritiated thymidine into the T cells. PBMC were stimulated with anti-CD3 in the presence ofvarious concentrations ofHPIV3, and tritiated thymidine incorporation was assessed (Fig. 4) . There was a dose-dependent inhibition of incorporation by the virus. Even a dose of 0.04 pfu per cell, which does not result in detectable viral infection within the time frame ofthe experiment (data not shown), mediated a profound inhibition of tritiated thymidine incorporation.
DISCUSSION
We have shown that nontransformed human T cells are readily infected by HPIV3 and that this infection leads to the production of infective virions. Our data show that infection is absolutely dependent on the activation of the T cells and, furthermore, that the proliferative capacity of the activated T cells is profoundly affected by exposure to the virus.
The effect of HPIV3 exposure on T-cell proliferation are reflected by (i) an abortive proliferation after an activating stimulus; (ii) the failure of IL-2 to restore the proliferation of (27, 28) and infection in vivo is immunosuppressive.
HPIV3 has the potential to both persist and to reinfect in vivo (1, 6-10); however, the mechanisms for these phenomena have not make anti-HPIV3 antibodies and recover from the infection, indicating that the specific immune response is not totally obliterated. However, the capacity of the virus to reinfect and persist is distinctly different from the situation with measles virus infection, which results in lifelong immunity. It is possible that HPIV3 infection preferentially inhibits the establishment of specific anti-HPIV3 memory T cells. The role of specific T cells in the immune response to HPIV3 has not been investigated.
The requirement for cellular activation to obtain productive infection of T cells by HPIV3 is a requirement similar for several other viruses that infect T cells (18) (19) (20) (21) (22) (23) . It seems most likely that activation of the cell is necessary for the establishment of the cellular machinery needed for viral replication. In this regard it is interesting to note that HPIV3 infection reaches a plateau value between 30%o and 40% of PBMC or T-cell clones. It appears that the plateau values are a reflection of the dynamics of the culture, which are clearly affected by the presence of viral particles.
Other viruses infect activated T cells to different levels in vitro. Measles virus infects >80%o of PBMC (25) while another paramyxovirus, mumps virus, infects 95% (29) . Cytomegalovirus infection of activated PBMC is limited to only 1-3% of the cells (27) . A recent report indicates that cytomegalovirus viral antigens are preferentially expressed in a small subpopulation of CD8+ T cells (28) . The variation in the capacity to express viral antigens in activated PBMC probably represents significant differences in the viral mechanisms at work.
The mechanism of immunoregulation mediated by HPIV3 has not been elucidated. It is possible that viral proteins interact with cellular proteins that mediate proliferative responses, thereby inhibiting their function. Alternatively, the presence of the virus may induce the secretion of an inhibitory cytokine, such as transforming growth factor (. The functional alterations in the measles virus-infected T cells can be explained by direct viral infection or cytopathic effects, since most of the cells are infected (25) . In contrast, productive viral infection cannot explain the marked functional alterations in the HPIV3-exposed T cells, since detectable viral protein synthesis as detected by immunohistology was not required for profound inhibition of T-cell proliferation. 
